Your weekly roundup of the latest news from Drug Topics®.
Iowa Senator Chuck Grassley is pushing the FTC to investigate PBM practices.
Patients taking the blood pressure medication required less insulin and demonstrated immunomodulatory benefits.
Approval was based on results of the phase 3 OlympiA trial.
A group of specialists discuss overdoses and treatment with naloxone so family and caregivers are prepared for the future and for treatment.
OTC remedies are widely available, but some carry drug-drug or drug-disease interactions that pharmacists should be aware of.